- Không có dữ liệu
Tiếng Việt
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
A new article published in Optoelectronic Science reviews the basic principles and applications of optical capture of optical nanoparticles. Optical nanoparticles are one of the key elements in photonics. They can not only perform optical imaging on various systems, but also serve as highly sensitive remote sensors.Recently, the success of optical tweezers in separating and manipulating individual...
In the field of optoelectronics, researchers from Busan National University in South Korea and the University of Oxford in the UK have successfully improved the signal amplification ability of CsPbBr3 perovskite nanosheets through innovative patterned waveguide methods, bringing new possibilities for the future of optoelectronics. This breakthrough not only has potential applications in fields suc...
Researchers from Sichuan University, the Key Laboratory of Advanced Special Materials and Preparation Processing Technology of the Ministry of Education, and the Nuclear Additive Manufacturing Laboratory of China Nuclear Power Research and Design Institute reported on the study of the ultra capillary performance of laser powder bed melting additive manufacturing composite structure liquid absorbin...
Recently, a research team from the Aerospace Laser Technology and Systems Department of the Shanghai Institute of Optics and Fine Mechanics, Chinese Academy of Sciences, proposed a new holographic imaging technology using frequency domain direct sampling. The relevant results were published in Optics Letters under the title of "Fourier inspired single pixel holography".Digital holography is a tech...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...